J&J KETOCONAZOLE 1% DANDRUFF SHAMPOO Rx-TO-OTC SWITCH UNANIMOUSLY SUPPORTED BY FDA COMMITTEES; ANTIFUNGAL CONCENTRATION, MECHANISM OF ACTION DISCUSSED
Executive Summary
The Rx-to-OTC switch of Johnson & Johnson's ketoconazole 1% dandruff shampoo gained a unanimous approval endorsement from FDA's Dermatologic Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee at a joint meeting Feb. 16.